Терапевтический архив (Jun 2013)
Efficiency and safety of lipid-lowering therapy for chronic kidney disease
Abstract
The paper considers the problem of lipid-lowering therapy for chronic kidney disease, by using different groups of drugs, the expediency, efficiency, and safety of the therapy at different disease stages, including end-stage renal failure, and replacement treatments.